Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 4573756, 13 pages
https://doi.org/10.1155/2017/4573756
Clinical Study

Evaluation of Inflammatory Markers in a Large Sample of Obstructive Sleep Apnea Patients without Comorbidities

Sleep Disorders Center, Department of Thoracic Medicine, University of Crete, Heraklion, Greece

Correspondence should be addressed to Izolde Bouloukaki; moc.liamg@ihtlozi

Received 13 March 2017; Revised 19 June 2017; Accepted 3 July 2017; Published 31 July 2017

Academic Editor: Ariadne Malamitsi-Puchner

Copyright © 2017 Izolde Bouloukaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Peppard, T. Young, J. H. Barnet, M. Palta, E. W. Hagen, and K. M. Hla, “Increased prevalence of sleep-disordered breathing in adults,” American Journal of Epidemiology, vol. 177, no. 9, pp. 1006–1014, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Garvey, M. F. Pengo, P. Drakatos, and B. D. Kent, “Epidemiological aspects of obstructive sleep apnea,” Journal of Thoracic Disease, vol. 7, no. 5, pp. 920–929, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. D. Kent, S. Ryan, and W. T. McNicholas, “Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity,” Respiratory Physiology & Neurobiology, vol. 178, no. 3, pp. 475–481, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Arnaud, M. Dematteis, J. L. Pepin, J. P. Baguet, and P. Levy, “Obstructive sleep apnea, immuno-inflammation, and atherosclerosis,” Seminars in Immunopathology, vol. 31, no. 1, pp. 113–125, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Levy, J. L. Pepin, C. Arnaud, J. P. Baguet, M. Dematteis, and F. Mach, “Obstructive sleep apnea and atherosclerosis,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 400–410, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. W. T. McNicholas, “Obstructive sleep apnea and inflammation,” Progress in Cardiovascular Diseases, vol. 51, no. 5, pp. 392–399, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. W. E. Fleming, A. Ferouz-Colborn, M. K. Samoszuk et al., “Blood biomarkers of endocrine, immune, inflammatory, and metabolic systems in obstructive sleep apnea,” Clinical Biochemistry, vol. 49, no. 12, pp. 854–861, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. S. F. Guven, M. H. Turkkani, B. Ciftci, T. U. Ciftci, and Y. Erdogan, “The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea,” Sleep and Breathing, vol. 16, no. 1, pp. 217–221, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. C. G. D. Luca, C. Pacheco-Pereira, S. Aydinoz, P. W. Major, C. Flores-Mir, and D. Gozal, “Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis,” Journal of Clinical Sleep Medicine, vol. 11, no. 1, pp. 27–36, 2015. View at Google Scholar
  10. C. G. D. Luca, C. Pacheco-Pereira, S. Aydinoz, P. W. Major, C. Flores-Mir, and D. Gozal, “Biomarkers associated with obstructive sleep apnea: a scoping review,” Sleep Medicine Reviews, vol. 23, pp. 28–45, 2015. View at Google Scholar
  11. H. A. Chami, J. D. Fontes, R. S. Vasan et al., “Vascular inflammation and sleep disordered breathing in a community-based cohort,” Sleep, vol. 36, no. 5, pp. 763–768, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Hirotsu, S. Tufik, C. Guindalini, D. R. Mazzotti, L. R. Bittencourt, and M. L. Andersen, “Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample,” PloS One, vol. 8, no. 6, article e66891, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. T. Maeder, W. Strobel, M. Christ et al., “Comprehensive biomarker profiling in patients with obstructive sleep apnea,” Clinical Biochemistry, vol. 48, no. 4-5, pp. 340–346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. S. B. Montesi, E. K. Bajwa, and A. Malhotra, “Biomarkers of sleep apnea,” Chest, vol. 142, no. 1, pp. 239–245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Williams and S. M. Scharf, “Obstructive sleep apnea, cardiovascular disease, and inflammation - is NF-kappa B the key?” Sleep and Breathing, vol. 11, no. 2, pp. 69–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Gozal and L. Kheirandish-Gozal, “Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 4, pp. 369–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. M. Lui and M. Sau-Man, “OSA and atherosclerosis,” Journal of Thoracic Disease, vol. 4, no. 2, pp. 164–172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Taheri, D. Austin, L. Lin, F. J. Nieto, T. Young, and E. Mignot, “Correlates of serum C-reactive protein (CRP)—no association with sleep duration or sleep disordered breathing,” Sleep, vol. 30, no. 8, pp. 991–996, 2007. View at Publisher · View at Google Scholar
  19. J. Volná, D. Kemlink, M. Kalousová et al., “Biochemical oxidative stress-related markers in patients with obstructive sleep apnea,” Medical Science Monitor, vol. 17, no. 9, pp. CR491–CR497, 2011. View at Google Scholar
  20. S. Steiner, T. Jax, S. Evers, M. Hennersdorf, A. Schwalen, and B. E. Strauer, “Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk,” Cardiology, vol. 104, no. 2, pp. 92–96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Shamsuzzaman, R. S. Amin, A. D. Calvin, D. Davison, and V. K. Somers, “Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients,” Sleep and Breathing, vol. 18, no. 4, pp. 761–766, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Natali, A. L’Abbate, and E. Ferrannini, “Erythrocyte sedimentation rate, coronary atherosclerosis, and cardiac mortality,” European Heart Journal, vol. 24, no. 7, pp. 639–648, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. B. Andresdottir, N. Sigfusson, H. Sigvaldason, and V. Gudnason, “Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik study,” American Journal of Epidemiology, vol. 158, no. 9, pp. 844–851, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Y. Min, J. Y. Jang, H. Y. Kim et al., “A relationship between the obstructive sleep apnea syndrome and the erythrocyte sedimentation rate,” Clinical and Experimental Otorhinolaryngology, vol. 2, no. 3, pp. 126–130, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Peled, M. Kassirer, M. R. Kramer et al., “Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome,” Thrombosis Research, vol. 121, no. 5, pp. 631–636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. L. F. Drager, H. F. Lopes, C. Maki-Nunes et al., “The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome,” PloS One, vol. 5, no. 8, article e12065, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. L. Verhulst, K. Hoeck, N. Schrauwen et al., “Sleep-disordered breathing and uric acid in overweight and obese children and adolescents,” Chest, vol. 132, no. 1, pp. 76–80, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. W. Johns, “A new method for measuring daytime sleepiness: the Epworth sleepiness scale,” Sleep, vol. 14, no. 6, pp. 540–545, 1991. View at Publisher · View at Google Scholar
  29. R. B. Berry, R. Brooks, C. E. Gamaldo et al., The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0, American Academy of Sleep Medicine, Darien, Illinois, 2012, http://www.Aasmnet.Org.
  30. V. K. Somers, D. P. White, R. Amin et al., “Sleep apnea and cardiovascular disease: an American Heart Association/American College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health),” Circulation, vol. 118, no. 10, pp. 1080–1111, 2008. View at Google Scholar
  31. H. K. Yaggi, J. Concato, W. N. Kernan, J. H. Lichtman, L. M. Brass, and V. Mohsenin, “Obstructive sleep apnea as a risk factor for stroke and death,” The New England Journal of Medicine, vol. 353, no. 19, pp. 2034–2041, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Arzt, T. Young, L. Finn, J. B. Skatrud, and T. D. Bradley, “Association of sleep-disordered breathing and the occurrence of stroke,” American Journal of Respiratory and Critical Care Medicine, vol. 172, no. 11, pp. 1447–1451, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. S. Shamsuzzaman, M. Winnicki, P. Lanfranchi et al., “Elevated C-reactive protein in patients with obstructive sleep apnea,” Circulation, vol. 105, no. 21, pp. 2462–2464, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. P. M. Ridker, “C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus,” Journal of the American College of Cardiology, vol. 49, no. 21, pp. 2129–2138, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. C. M. Albert, J. Ma, N. Rifai, M. J. Stampfer, and P. M. Ridker, “Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death,” Circulation, vol. 105, no. 22, pp. 2595–2599, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Koenig, M. Sund, M. Fröhlich et al., “C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg cohort study, 1984 to 1992,” Circulation, vol. 99, no. 2, pp. 237–242, 1999. View at Google Scholar
  37. A. D. Pradhan, J. E. Manson, J. E. Rossouw et al., “Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study,” The Journal of the American Medical Association, vol. 288, no. 8, pp. 980–987, 2002. View at Publisher · View at Google Scholar
  38. O. Kokturk, T. U. Ciftci, E. Mollarecep, and B. Ciftci, “Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome,” International Heart Journal, vol. 46, no. 5, pp. 801–809, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. N. M. Punjabi and B. A. Beamer, “C-reactive protein is associated with sleep disordered breathing independent of adiposity,” Sleep, vol. 30, no. 1, pp. 29–34, 2007. View at Publisher · View at Google Scholar
  40. T. Yokoe, K. Minoguchi, H. Matsuo et al., “Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure,” Circulation, vol. 107, no. 8, pp. 1129–1134, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Hayashi, K. Fujimoto, K. Urushibata, A. Takamizawa, O. Kinoshita, and K. Kubo, “Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome,” Respirology, vol. 11, no. 1, pp. 24–31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Steiropoulos, N. Papanas, E. Nena et al., “Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?” Mediators of Inflammation, vol. 2010, Article ID 675320, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Nadeem, J. Molnar, E. M. Madbouly et al., “Serum inflammatory markers in obstructive sleep apnea: a meta-analysis,” Journal of Clinical Sleep Medicine, vol. 9, no. 10, pp. 1003–1012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Vasse, J. Paysant, J. Soria, J. P. Collet, J. P. Vannier, and C. Soria, “Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk,” Haemostasis, vol. 26, Supplement 4, pp. 331–339, 1996. View at Google Scholar
  45. V. Palmieri, A. Celentano, M. J. Roman et al., “Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the strong heart study,” American Heart Journal, vol. 145, no. 3, pp. 467–474, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. Emerging Risk Factors Collaboration, S. Kaptoge, E. Di Angelantonio et al., “C-reactive protein, fibrinogen, and cardiovascular disease prediction,” New England Journal of Medicine, vol. 367, no. 14, pp. 1310–1320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. T. E. Wessendorf, A. F. Thilmann, Y.-M. Wang, A. Schreiber, N. Konietzko, and H. Teschler, “Fibrinogen levels and obstructive sleep apnea in ischemic stroke,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2039–2042, 2000. View at Publisher · View at Google Scholar
  48. R. Tkacova, Z. Dorkova, A. Molcanyiova, Z. Radikova, I. Klimes, and I. Tkac, “Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea,” Medical Science Monitor, vol. 14, no. 9, pp. CR438–CR444, 2008. View at Google Scholar
  49. J. R. Timmer, J. P. Ottervanger, J. C. Hoorntje et al., “Prognostic value of erythrocyte sedimentation rate in ST segment elevation myocardial infarction: interaction with hyperglycaemia,” Journal of Internal Medicine, vol. 257, no. 5, pp. 423–429, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Saito, M. Nishimura, E. Shibuya et al., “Tissue hypoxia in sleep apnea syndrome assessed by uric acid and adenosine,” Chest, vol. 122, no. 5, pp. 1686–1694, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Kanbay, H. Inonu, Y. Solak et al., “Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome,” European Journal of Internal Medicine, vol. 25, no. 5, pp. 471–476, 2014. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Plywaczewski, M. Bednarek, L. Jonczak, D. Gorecka, and P. Sliwiniski, “Hyperuricaemia in males with obstructive sleep apnoea (OSA),” Pneumonologia I Alergoloia Polska, vol. 73, no. 3, pp. 254–259, 2005. View at Google Scholar
  53. R. Plywaczewski, M. Bednarek, L. Jonczak, D. Gorecka, and P. Sliwinski, “Hyperuricaemia in females with obstructive sleep apnoea,” Pneumonologia I Alergoloia Polska, vol. 74, no. 2, pp. 159–165, 2006. View at Google Scholar
  54. A. R. García, Á. S. Armengol, E. L. Crespo et al., “Blood uric acid levels in patients with sleep disordered breathing,” Archivos de Bronconeumologia, vol. 42, no. 10, pp. 492–500, 2006. View at Publisher · View at Google Scholar
  55. H. S. Hira, A. Shukla, A. Kaur, and S. Kapoor, “Serum uric acid and lactate levels among patients with obstructive sleep apnea syndrome: which is a better marker of hypoxemia?” Annals of Saudi Medicine, vol. 32, no. 1, pp. 37–42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Kosacka, A. Brzecka, P. Piesiak, A. Korzeniewska, and R. Jankowska, “Soluble ligand CD40 and uric acid as markers of atheromatosis in patients with obstructive sleep apnea,” Advances in Experimental Medicine and Biology, vol. 839, pp. 55–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  57. I. Bouloukaki, C. Mermigkis, E. M. Kallergis, V. Moniaki, E. Mauroudi, and S. E. Schiza, “Obstructive sleep apnea syndrome and cardiovascular disease: the influence of C-reactive protein,” World Journal of Experimental Medicine, vol. 5, no. 2, pp. 77–83, 2015. View at Publisher · View at Google Scholar
  58. C. Mermigkis, I. Bouloukaki, D. Mermigkis et al., “CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role?” Sleep and Breathing, vol. 16, no. 3, pp. 813–819, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Yardim-Akaydin, E. Caliskan-Can, H. Firat, S. Ardic, and B. Simsek, “Influence of gender on C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in obstructive sleep apnea,” Anti-Inflammatory and Anti-Allergy Agents in Medical Chemistry, vol. 13, no. 1, pp. 56–63, 2014. View at Google Scholar